Related Experiment Video
Updated: May 7, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?
Abstract:
Intracerebral hemorrhage (ICH, or macrobleeds) and cerebral microbleeds-smaller foci of hemosiderin deposits commonly detected by magnetic resonance imaging of older adults with or without ICH-are both associated with an increased risk of future ICH. These hemorrhagic pathologies also share risk factors with ischemic thromboembolic conditions that may require antithrombotic therapy, requiring specialists in cardiology, internal medicine, and neurology to weigh the benefits vs hemorrhagic risks of antithrombotics in individual patients. This paper will review recent advances in our understanding of hemorrhage prone cerebrovascular pathologies with a particular emphasis on use of these markers in decision making for antithrombotic use.
Insights
Intracerebral hemorrhage and microbleeds increase future stroke risk. Understanding these conditions helps doctors balance antithrombotic therapy benefits against bleeding risks in patients.
Area of Science:
- Neurology
- Vascular Medicine
- Radiology
Background:
- Intracerebral hemorrhage (ICH) and cerebral microbleeds are associated with increased risk of future ICH.
- These hemorrhagic pathologies share risk factors with ischemic conditions requiring antithrombotic therapy.
Purpose of the Study:
- Review recent advances in understanding hemorrhage-prone cerebrovascular pathologies.
- Emphasize the use of hemorrhage markers in antithrombotic therapy decision-making.
Main Methods:
- Literature review of recent advances in cerebrovascular pathology.
- Analysis of risk factors common to hemorrhagic and ischemic conditions.
- Evaluation of diagnostic markers for hemorrhage risk.
Main Results:
- Both ICH and microbleeds are significant predictors of future ICH events.
- Shared risk factors necessitate careful consideration of antithrombotic therapy.
- Diagnostic imaging markers aid in risk stratification.
Conclusions:
- Hemorrhage-prone pathologies require careful management, especially when considering antithrombotic treatment.
- Individualized patient assessment is crucial to balance antithrombotic benefits against bleeding risks.
- Further research into hemorrhage markers can optimize clinical decision-making for antithrombotic use.
More Related Videos
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management

